FULL PRESCRIBING INFORMATION
1HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the INFORMATION needed to use JYNARQUE safely and effectively. See full PRESCRIBING INFORMATION for (tolvaptan) tablets for oral useInitial Approval: 2009WARNING: RISK OF SERIOUS LIVER INJURYSee full PRESCRIBING INFORMATION for complete boxed (tolvaptan) can cause serious and potentially fatal liver injury. Acute liver failure requiring liver transplantation has been reported ( )xMeasure transaminases and bilirubin before initiating treatment, at 2 weeks and 4 weeks after initiation, then continuing monthly for the first 18 months and every 3 months thereafter ( )xJYNARQUE is available only through a restricted distribution program called the JYNARQUE REMS Program ( ).
JYNARQUE is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage The initial dosage for JYNARQUE is 60 mg orally per day as 45 mg taken on waking and 15 mg taken 8 hours later.
Download FULL PRESCRIBING INFORMATION
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: